Barnard RD. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951;51:2399–402.Search in Google Scholar
Brittingham TE, Chaplin H Jr. Febrile transfusion reactions caused by sensitivity to donor leukocytes and platelets. JAMA 1957;165:819–25.10.1001/jama.1957.0298025005301313462853Search in Google Scholar
Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573–7.10.1046/j.1537-2995.1985.25686071434.x4071603Search in Google Scholar
Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266–73.10.1182/blood-2004-07-292915572582Search in Google Scholar
Silliman CC, Boshkov L, Mehdizadehkashi Z, et al. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454–62.10.1182/blood-2002-03-095812393667Search in Google Scholar
Bux J, Sachs U. The pathogenesis of transfusion-related acute lung injury. Br J Hematol 2007;136:788–99.10.1111/j.1365-2141.2007.06492.x17341264Search in Google Scholar
Kleinman S, Caulfield T, Chan P, et al. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774–89.10.1111/j.0041-1132.2004.04347.x15584994Search in Google Scholar
Church GD, Price C, Sanchez R, Looney MR. Transfusion-related acute lung injury in the pediatric patient: two case reports and a review of the literature. Transfus Med 2006;16:343–8.10.1111/j.1365-3148.2006.00683.x16999757Search in Google Scholar
Skeate RC, Eastlund T. Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol 2007;14:682–7.10.1097/MOH.0b013e3282ef195a17898575Search in Google Scholar
Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion-associated circulatory overload from transfusion-related acute lung injury. Crit Care Med 2006;34(5 Suppl):S109–13.10.1097/01.CCM.0000214311.56231.2316617253Search in Google Scholar
Tobian AA, Sokoll LJ, Tisch DJ, Ness PM, Shan H. N-terminal pro-brain natriuretic peptide is a useful diagnostic marker for transfusion-associated circulatory overload. Transfusion 2008;48:1143–50.10.1111/j.1537-2995.2008.01656.x18298592Search in Google Scholar
Li G, Daniels CE, Kojicic M, et al. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill. Transfusion 2009;49:13–20.10.1111/j.1537-2995.2008.01941.x275238218954397Search in Google Scholar
Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968–71.10.1001/jama.287.15.196811960539Search in Google Scholar
Clifford L, Singh A, Wislon GA, et al. Electronic health record surveillance algorithms facilitate the detection of transfusion-related pulmonary complications. Transfusion 2013;53: 1205–16.10.1111/j.1537-2995.2012.03886.x483948422934792Search in Google Scholar
Eder A, Herron R, Strupp A, et al. Effective reduction of transfusion-related acute lung injury risk with male-predominant plasma strategy in the American Red Cross (2006–2008). Transfusion 2010;50:1732–42.10.1111/j.1537-2995.2010.02652.x20456698Search in Google Scholar
Eder A, Dy B, Perez J, Rambaud M, Benjamin RJ. The residual risk of transfusion-related acute lung injury at the American Red Cross (2008–2011): limitations of a predominantly male-donor plasma mitigation strategy. Transfusion 2013;53: 1442–9.10.1111/j.1537-2995.2012.03935.x23113676Search in Google Scholar
Arinsburg S, Skerrett D, Karp J, et al. Conversion to low transfusion-related acute lung injury-risk plasma significantly reduces TRALI. Transfusion 2012;52:946–52.10.1111/j.1537-2995.2011.03403.x22060800Search in Google Scholar
U.S. Food and Drug Administration. Fatalities reported to FDA following blood collection and transfusion: annual summary for fiscal year 2013. Available at: http://www.fda.gov/ BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/ TransfusionDonationFatalities/ucm391574.htm.Search in Google Scholar
Kleinman S, Grossman B, Kopko P. A national survey of transfusion-related acute lung injury risk reduction policies for platelets and plasma in the United States. Transfusion 2010;50:1312–21.10.1111/j.1537-2995.2010.02659.x20456690Search in Google Scholar
Process control standard 5.4.1.2. Standards for blood banks and transfusion services. 29th ed. Arlington, VA: American Association of Blood Banks, 2014:17.Search in Google Scholar
Popovsky MA, Haley NR. Further characterization of transfusion related acute lung injury: demographics, clinical and laboratory features and morbidity. Immunohematology 2000;16:157–9.10.21307/immunohematology-2019-599Search in Google Scholar
